A Comprehensive Review of Recent Studies on Herb-Drug Interaction: A Focus on Pharmacodynamic Interaction

Journal of Alternative and Complementary Medicine

Volumn 22, Issue 4, 2016, Pages 262-279

  Choi, Jin Gyu ^a   Eom, Sang Min ^b   Kim, Jaeyoung ^b   Kim, Soon Han ^b   Huh, Eugene ^b   Kim, Hocheol ^b   Lee, Yunwoo ^c   Lee, Hyangsook ^b   Oh, Myung Sook ^a,b  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

^c Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANGELICA SINENSIS EXTRACT; BETEL EXTRACT; CIPROFLOXACIN; CODEINE; COTRIMOXAZOLE; CRATAEGUS EXTRACT; CUSCUTA CHINENSIS EXTRACT; CYCLOSPORIN; DIAZEPAM; DIGOXIN; DOXORUBICIN; FLUOROURACIL; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLIBENCLAMIDE; HERBACEOUS AGENT; LIGUSTICUM CHUANXIONG EXTRACT; MIDAZOLAM; NITROPRUSSIDE SODIUM; OCIMUM GRATISSIMUM EXTRACT; PANAX NOTOGINSENG EXTRACT; PEPPERMINT; PRESCRIPTION DRUG; SILDENAFIL; TAMOXIFEN; TOLBUTAMIDE; UNCARIA TOMENTOSA EXTRACT; UNINDEXED DRUG; PLANT MEDICINAL PRODUCT;

ANGELICA SINENSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG METABOLISM; DRUG POTENTIATION; GARLIC; GINSENG; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; HYPERTENSION; IN VITRO STUDY; LONG TERM CARE; NEOPLASM; NONHUMAN; OCIMUM GRATISSIMUM; PANAX NOTOGINSENG; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; ANIMAL; CLINICAL STUDY; MEDICAL RESEARCH; MOUSE; RAT;

ANIMALS; BIOMEDICAL RESEARCH; CLINICAL STUDIES AS TOPIC; HERB-DRUG INTERACTIONS; HUMANS; MICE; PLANT PREPARATIONS; RATS;

EID: 84964413468     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2015.0235     Document Type: Review

References (118)

1. Garodia P, Ichikawa H, Malani N, et al. From ancient medicine to modern medicine: Ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integrat Oncol 2007;5:25-37.
2. Che CT, Wang ZJ, Chow MS, Lam CW. Herb-herb combination for therapeutic enhancement and advancement: Theory, practice and future perspectives. Molecules 2013;18:5125-5141.
3. Robinson M, Zhang X. The World Medicines Situation Report. WHO/EMP/MIE/2. 3. Traditional Medicines: Global Situation, Issues and Challenges. Geneva, Switzerland: World Health Organization, 2011.
4. de Lima Toccafondo Vieira M, Huang SM. Botanicaldrug interactions: A scientific perspective. Planta Medica 2012;78:1400-1415.
5. Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: A European survey. Ann Oncol 2005;16:655-663.
6. Engdal S, Steinsbekk A, Klepp O, Nilsen OG. Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway. Support Care Cancer 2008;16:763-769.
7. Bensoussan A, Myers SP, Wu SM, O'Connor K. Naturopathic and Western herbal medicine practice in Australia -A workforce survey. Complement Ther Med 2004;12:17-27.
8. Lu WI, Lu DP. Impact of Chinese herbal medicine on American society and health care system: perspective and concern. Evidence Based Complement Alternat Med 2014;2014:251891.
9. Van Wyk BE, van Oudtshoorn B, Gericke N. Medicinal Plants of South Africa. 2nd ed. Queenswood, South Africa: Briza Publications, 2009.
10. Chen MC, Lai JN, Chen PC, Wang JD. Concurrent use of conventional drugs with Chinese herbal products in Taiwan: A population-based study. J Trad Complement Med 2013;3:256-262.
11. Wang BR, Chang YL, Chen TJ, et al. Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: Analysis of national insurance claims. Patient Prefer Adherence 2014; 8:671-682.
12. Seo HJ, Baek SM, Kim SG, et al. Prevalence of complementary and alternative medicine use in a communitybased population in South Korea: A systematic review. Complement Ther Med 2013;21:260-271.
13. Cramer H, Cohen L, Dobos G, Witt CM. Integrative oncology: best of both worlds-theoretical, practical, and research issues. Evidence Based Complement Alternat Med 2013;2013:383142.
14. Chan E, Tan M, Xin J, et al. Interactions between traditional Chinese medicines and Western therapeutics. Curr Opin Drug Discov Develop 2010;13:50-65.
15. Klepser TB, Doucette WR, Horton MR, et al. Assessment of patients' perceptions and beliefs regarding herbal therapies. Pharmacotherapy 2000;20:83-87.
16. Lau WC WT, Shields T, Rubenfire M, Tantry US, Gurbel PA. The effect of St John's Wort on the pharmacodynamic response of clopidogrel in hyporesponsive volunteers and patients: increased platelet inhibition by enhancement of CYP3A4 metabolic activity. J Cardiovasc Pharmacol 2011; 57:86-93.
17. Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355:134-138.
18. Tarirai C, Viljoen AM, Hamman JH. Herb-drug pharmacokinetic interactions reviewed. Exp Opin Drug Metab Toxicol 2010;6:1515-1538.
19. Chan K. Understanding interactions between Chinese medicines and pharmaceutical drugs in integrative healthcare. Chin J Integrat Med 2015;21:83-89.
20. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controll Clin Trials 1996;17:1-12.
21. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 2002;287:337-344.
22. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Alternat Ther Health Med 2005;11:42-49.
23. World Health Organization. WHO Traditional Medicines Strategy 2014-2023. Online document at: www.who.int/medicines/publications/traditional/trm-strategy14-23/en/2013 accessed March 16, 2016.
24. Chen XW, Sneed KB, Pan SY, et al. Herb-drug interactions and mechanistic and clinical considerations. Curr Drug Metab 2012;13:640-651.
25. Ge B, Zhang Z, Zuo Z. Updates on the clinical evidenced herb-warfarin interactions. Evidence Based Complement Alternat Med 2014;2014:957362.
26. Posadzki P, Watson L, Ernst E. Herb-drug interactions: An overview of systematic reviews. Br J Clin Pharmacol 2013; 75:603-618.
27. World Health Organization. National policy on traditional medicine and regulation of herbal medicines. Report of a WHO global survey. Online document at: http://apps. who. int/medicinedocs/en/d/Js7916e/, accessed March 16, 2016.
28. Centers for Disease Control and Prevention. Ambulatory health care data. National Hospital Ambulatory Medical Care Survey: 2011 Emergency Department Summary Tables. Online document at: www. cdc. gov/nchs/data/ahcd/nhamcs- emergency/2011-ed-web-tables. pdf, accessed March 16, 2016.
29. U. S. Food and Drug Administration Consumer Health Information: Avoiding drug interactions. 2008. Online document at: www. fda. gov/ForConsumers/ConsumerUpdates/ ucm096386. htm, accessed March 16, 2016.
30. Tang SH, Chen JX, Wang YP, et al. Research ideas and strategies on the dose-effect relationship of traditional Chinese medicine prescriptions and herbs. J Tradit Chin Med 2012;32:110-113.
31. Wang X, Zhang H, Chen L, et al. Liquorice, a unique ''guide drug'' of traditional Chinese medicine: A review of its role in drug interactions. J Ethnopharmacol 2013;150: 781-790.
32. Wu CT, Lai JN, Tsai YT. The prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: A population-based study. PloS One 2014;9:e113887.
33. Jiang W, Wang X, Xu X, Kong L. Effect of Schisandra sphenanthera extract on the concentration of tacrolimus in the blood of liver transplant patients. Int J Clin Pharmacol Therap 2010;48:224-229.
34. Poonam T, Prakash GP, Kumar LV. Influence of Allium sativum extract on the hypoglycemic activity of glibenclamide: An approach to possible herb-drug interaction. Drug Metab Drug Interac 2013;28:225-230.
35. Asdaq SM, Inamdar MN. Pharmacodynamic interaction of captopril with garlic in isoproterenol-induced myocardial damage in rat. Phytother Res 2010;24:720-725.
36. Martinez-Vazquez M, Estrada-Reyes R, Araujo Escalona AG, et al. Antidepressant-like effects of an alkaloid extract of the aerial parts of Annona cherimolia in mice. J Ethnopharmacol 2012;139:164-170.
37. Sun K, Zhao C, Chen XF, et al. Ex vivo relaxation effect of Cuscuta chinensis extract on rabbit corpus cavernosum. Asian J Androl 2013;15:134-137.
38. Quílez AM1, Saenz MT, García MD. Uncaria tomentosa (Willd. ex. Roem. & Schult.) DC. And Eucalyptus globulus Labill. interactions when administered with diazepam. Phytother Res 2012;26:458-461.
39. Acosta M, II, Castaneda-Hernandez G, Cilia-Lopez VG, et al. Interaction between Heliopsis longipes extract and diclofenac on the thermal hyperalgesia test. Phytomedicine 2009;16:336-341.
40. Chan SS, Jones RL, Lin G. Synergistic interaction between the Ligusticum chuanxiong constituent butylidenephthalide and the nitric oxide donor sodium nitroprusside in relaxing rat isolated aorta. J Ethnopharmacol 2009;122:308-312.
41. Liu TP, Liu IM, Cheng JT. Improvement of insulin resistance by panax ginseng in fructose-rich chow-fed rats. Hormone Metabol Res 2005;37:146-151.
42. Balderas JL, Reza V, Ugalde M, et al. Pharmacodynamic interaction of the sedative effects of Ternstroemia pringlei (Rose) Standl. with six central nervous system depressant drugs in mice. J Ethnopharmacol 2008;119:47-52.
43. Kapadia GJ, Rao GS, Ramachandran C, et al. Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines. J Complement Integrat Med 2013;10: 113-122.
44. Phatthalung PN, Chusri S, Voravuthikunchai SP. Thai ethnomedicinal plants as resistant modifying agents for combating Acinetobacter baumannii infections. BMC Complement Alternat Med 2012;12:56.
45. Nweze EI, Eze EE. Justification for the use of Ocimum gratissimum L in herbal medicine and its interaction with disc antibiotics. BMC Complement Alternat Med 2009;9:37.
46. Yu ML, Zhang CL, Yuan DD, et al. Panax notoginseng saponins enhances the cytotoxicity of cisplatin via increasing gap junction intercellular communication. Biol Pharmaceut Bull 2012;35:1230-123 7.
47. Ng PL, Rajab NF, Then SM, et al. Piper betle leaf extract enhances the cytotoxicity effect of 5-fluorouracil in inhibiting the growth of HT29 and HCT116 colon cancer cells. J Zhejiang Univ 2014;15:692-700.
48. Dai ZK, Yang XS, Yu LM. [Anticancer effect of 5-fluorouracil combined with extract of Rosa roxburghii Tratt on human endometrial adenocarcinoma]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2011;31:1108-1112, 1117.
49. Zhou Z, Nair MG, Claycombe KJ. Synergistic inhibition of interleukin-6 production in adipose stem cells by tart cherry anthocyanins and atorvastatin. Phytomedicine 2012; 19:878-881.
50. Sabova L, Pilatova M, Szilagyi K, et al. Cytotoxic effect of mistletoe (Viscum album L.) extract on Jurkat cells and its interaction with doxorubicin. Phytother Res 2010; 24:365-368.
51. Strippoli S, Lorusso V, Albano A, Guida M. Herbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin. BMC Complement Alternat Med 2013;13:199.
52. Dardano A, Ballardin M, Caraccio N, et al. The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with iodine-131. Thyroid 2012;22:318-324.
53. Doh KC, Lim SW, Piao SG, et al. Ginseng treatment attenuates chronic cyclosporine nephropathy via reducing oxidative stress in an experimental mouse model. Am J Nephrol 2013;37:421-433.
54. Liu L, Shi R, Shi Q, et al. Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice. Planta Medica 2008;74:203-209.
55. Shi R, Liu L, Huo Y, Cheng YY. [Study on protective effects of Panax notoginseng saponins on doxorubicininduced myocardial damage]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007;32:2632-2635.
56. Al Faraj S. Antagonism of the anticoagulant effect of warfarin caused by the use of Commiphora molmol as a herbal medication: A case report. Ann Trop Med Parasitol 2005;99:219-220.
57. Guo CX, Pei Q, Yin JY, et al. Effects of Ginkgo biloba extracts on pharmacokinetics and efficacy of atorvastatin based on plasma indices. Xenobiotica 2012;42:784-790.
58. Nowack R, Nowak B. Herbal teas interfere with cyclosporin levels in renal transplant patients. Nephrol Dial Transplant 2005;20(11):2554-2556.
59. Van Strater AC, Bogers JP. Interaction of St John's wort (Hypericum perforatum) with clozapine. Int Clin Phycopharmacol 2012;27:121-124.
60. Xu H, Williams KM, Liauw WS, et al. Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Br J Pharmacol 2008; 153:1579-1586.
61. Andren L, Andreasson A, Eggertsen R. Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia. Eur J Clin Pharmacol 2007;63:913-916.
62. Murphy PA, Kern SE, Stanczyk FZ, Westhoff CL. Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception 2005;71:402-408.
63. Jiang X, Williams KM, Liauw WS, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2004;57:592-599.
64. Carbajal R, Yisfalem A, Pradhan N, et al. Case report: boldo (Peumus boldus) and tacrolimus interaction in a renal transplant patient. Transplantat Proc 2014;46:2400-2402.
65. Prasad KP, Tharangani PG, Samaranayake CN. Recurrent relapses of depression in a patient established on sertraline after taking herbal medicinal mixtures -A herb-drug interaction? J Psychopharmacol 2009;23:216-219.
66. Taki Y, Hagiwara E, Hirose C, et al. Effects of Ginkgo biloba extract on the pharmacokinetics and pharmacodynamics of tolbutamide in protein-restricted rats. J Pharm Pharmacol 2011;63:1238-1243.
67. Dasgupta A, Kidd L, Poindexter BJ, Bick RJ. Interference of hawthorn on serum digoxin measurements by immunoassays and pharmacodynamic interaction with digoxin. Arch Pathol Lab Med 2010;134:1188-1192.
68. Man S, Li Y, Fan W, et al. Combination therapy of cyclophosphamide and Rhizoma Paridis Saponins on antihepatocarcinoma mice and effects on cytochrome p450 enzyme expression. Steroids 2014;80:1-6.
69. Samojlik I, Petkovic S, Mimica-Dukic N, Bozin B. Acute and chronic pretreatment with essential oil of peppermint (Mentha x piperita L., Lamiaceae) influences drug effects. Phytother Res 2012;26:820-825.
70. Samojlik I, Mijatovic V, Petkovic S, et al. The influence of essential oil of aniseed (Pimpinella anisum, L.) on drug effects on the central nervous system. Fitoterapia 2012;83: 1466-1473.
71. Wang X, Lee WY, Zhou X, et al. A pharmacodynamicspharmacokinetic (PD-PK) study on the effects of Danshen (Salvia miltiorrhiza) on midazolam, a model CYP3A probe substrate, in the rat. Phytomedicine 2010;17:876-883.
72. Elmer GW, Lafferty WE, Tyree PT, Lind BK. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. Ann Pharmacother 2007;41:1617-1624.
73. Saw JT, Bahari MB, Ang HH, Lim YH. Potential drugherb interaction with antiplatelet/anticoagulant drugs. Complement Ther Clin Pract 2006;12:236-241.
74. Lee A, Chui PT, Aun CS, et al. Possible interaction between sevoflurane and Aloe vera. Ann Pharmacother 2004; 38:1651-1654.
75. Acikgoz SK, Acikgoz E. Gastrointestinal bleeding secondary to interaction of Artemisia absinthium with warfarin. Drug Metab Drug Interact 2013;28:187-189.
76. Turfan M, Tasal A, Ergun F, Ergelen M. [A sudden rise in INR due to combination of Tribulus terrestris, Avena sativa, and Panax ginseng (Clavis Panax)]. Turk Kardiyoloji Dernegi Arsivi 2012;40:259-261.
77. Mohammed Abdul MI, Jiang X, Williams KM, et al. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol 2008;154:1691-1700.
78. Rivera CA, Ferro CL, Bursua AJ, Gerber BS. Probable interaction between Lycium barbarum (Goji) and warfarin. Pharmacotherapy 2012;32:e50-53.
79. Segal R, Pilote L. Warfarin interaction with Matricaria chamomilla. CMAJ 2006;174:1281-1282.
80. Lambert JP, Cormier J. Potential interaction between warfarin and boldo-fenugreek. Pharmacotherapy 2001;21: 509-512.
81. Lee NJ, Fermo JD. Warfarin and royal jelly interaction. Pharmacotherapy 2006;26:583-586.
82. Shalansky S, Lynd L, Richardson K, et al. Risk of warfarinrelated bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: A longitudinal analysis. Pharmacotherapy 2007;27:1237-1247.
83. Ferreira PG, Costa S, Dias N, et al. Simultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxine. 2014;40:313-318.
84. Kupiec T, Raj V. Fatal seizures due to potential herb-drug interactions with Ginkgo biloba. J Analyt Toxicol 2005; 29:755-758.
85. Tamura S, Warabi Y, Matsubara S. Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement. J Clin Pharm Therap 2012;37:724-725.
86. Sobieraj DM, Freyer CW. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus. Ann Pharmacother 2010;44:1334-1337.
87. Bilgi N, Bell K, Ananthakrishnan AN, Atallah E. Imatinib and Panax ginseng: A potential interaction resulting in liver toxicity. Ann Pharmacother 2010;44:926-928.
88. Carrasco MC, Vallejo JR, Pardo-de-Santayana M, et al. Interactions of Valeriana officinalis L. And Passiflora incarnata L. in a patient treated with lorazepam. Phytother Res 2009;23:1795-1796.
89. Taki Y, Yokotani K, Yamada S, et al. Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice. Phytomedicine 2012;19:177-182.
90. Chaplin RL Jr, Jedynak J, Johnson D, et al. The effects of valerian on the time course of emergence from general anesthesia in Sprague-Dawley rats (Rattus norvegicus). AANA J 2007;75:431-435.
91. Salman SA, Amrah S, Wahab MS, et al. Modification of propranolol's bioavailability by Eurycoma longifolia waterbased extract. J Clin Pharm Therap 2010;35:691-696.
92. Kim BH, Kim KP, Lim KS, et al. Influence of Ginkgo biloba extract on the pharmacodynamic effects and pharmacokinetic properties of ticlopidine: An open-label, randomized, two-period, two-treatment, two-sequence, single-dose crossover study in healthy Korean male volunteers. Clin Therap 2010;32:380-390.
93. Vardy J, Dhillon HM, Clarke SJ, et al. Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. Springer Plus 2013;2:126.
94. Kim HS, Kim GY, Yeo CW, et al. The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects. Br J Clin Pharmacol 2014;77:821-830.
95. Zhou Y, Zeng R. [Effects of Ginkgo biloba extract on anticoagulation and blood drug level of warfarin in healthy wolunteers]. Zhongguo Zhong Yao Za Zhi 2011;36:2290-2293.
96. Fan L, Zhou G, Guo D, et al. The pregnane X receptor agonist St John's Wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide. Clin Pharmacokinet 2011;50:605-611.
97. Lee YH, Lee BK, Choi YJ, et al. Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement. Int J Cardiol 2010;145:275-276.
98. Radwan MA, Baky NA, Zaghloul I, Aboul-Enein HY. Pharmacokinetics and cardiovascular effect of etoricoxib in the absence or presence of St. John's Wort in rats. Arzneimittel Forschung 2012;62:313-318.
99. Panossian A, Hovhannisyan A, Abrahamyan H, et al. Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats. Phytother Res 2009;23:351-357.
100. Dasgupta A, Peterson A, Wells A, Actor JK. Effect of Indian Ayurvedic medicine Ashwagandha on measurement of serum digoxin and 11 commonly monitored drugs using immunoassays: study of protein binding and interaction with Digibind. Arch Pathol Lab Med 2007;131: 1298-1303.
101. Cho BS, Kim SD, Park JK, et al. Effects of Bupleurum falcatum and its combination with an angiotensin II receptor blocker on cytokine and chemokine expression in human mesangial cells. Phytother Res 2010;24:339-343.
102. Weissenstein U, Kunz M, Urech K, Baumgartner S. Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro. BMC Complement Alternat Med 2014;14:6.
103. Zhang ZJ, Kang WH, Li Q, Tan QR. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebocontrolled studies. J Psychiatr Res 2007;41:828-836.
104. Ko CH, Siu WS, Wong HL, et al. In vivo study on the pharmacological interactions between a Chinese herbal formula ELP and antiresorptive drugs to counteract osteoporosis. Evidence Based Complement Altern Med 2012; 2012:203732.
105. Wang E, Bussom S, Chen J, et al. Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment. BMC Med Genom 2011;4:38.
106. Tsai YT, Lai JN, Wu CT. The use of Chinese herbal products and its influence on tamoxifen induced endometrial cancer risk among female breast cancer patients: A population-based study. J Ethnopharmacol 2014;155:1256-1262.
107. Ushio S, Egashira N, Sada H, et al. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. Eur J Cancer 2012; 48:1407-1413.
108. Hwang SW, Han HS, Lim KY, Han JY. Drug interaction between complementary herbal medicines and gefitinib. J Thorac Oncol 2008;3:942-943.
109. Hitoshi K, Katoh M, Tanaka Y, et al. Mechanism of drug interaction between a Kampo medicine, byakkokaninjinto, and tetracycline in rats. J Infect Chemother 2012;18:75-82.
110. Chen JL, Wang JY, Tsai YF, et al. In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab. Menopause 2013;20:646-654
111. Lala LG, D'Mello PM, Naik SR. Pharmacokinetic and pharmacodynamic studies on interaction of ''Trikatu'' with diclofenac sodium. J Ethnopharmacol 2004;91:277-280.
112. Malekzadeh F, Rose C, Ingvar C, Jernstrom H. [Natural remedies and hormone preparations-potential risk for breast cancer patients. A study surveys the use of agents which possibly counteract with the treatment]. Lakartidningen 2005;102:3226-3228, 3230-3221.
113. Molto J, Miranda C, Malo S, et al. [Use of herbal remedies among HIV-infected patients: patterns and correlates]. Medicina Clin 2012;138:93-98.
114. Iida R, Otsuka Y, Matsumoto K, et al. Pseudoaldosteronism due to the concurrent use of two herbal medicines containing glycyrrhizin: interaction of glycyrrhizin with angiotensin-converting enzyme inhibitor. Clin Exp Nephrol 2006;10:131-135.
115. Wong AL, Chan TY. Interaction between warfarin and the herbal product quilinggao. Ann Pharmacother 2003;37: 836-838.
116. Yang SH, Yu CL, Chen HY, Lin YH. A commonly used Chinese herbal formula, Shu-Jing-Hwo-Shiee-Tang, potentiates anticoagulant activity of warfarin in a rabbit model. Molecules 2013;18:11712-11723.
117. Wang P, Sun H, Yang L, et al. Absence of an effect of T89 on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. J Clin Pharmacol 2014;54:234-239.
118. Chu Y, Zhang L, Wang XY, et al. The effect of Compound Danshen Dripping Pills, a Chinese herb medicine, on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Ethnopharmacol 2011;137:1457-1461.